Andrew D Zelenetz

Andrew D Zelenetz

UNVERIFIED PROFILE

Are you Andrew D Zelenetz?   Register this Author

Register author
Andrew D Zelenetz

Andrew D Zelenetz

Publications by authors named "Andrew D Zelenetz"

Are you Andrew D Zelenetz?   Register this Author

100Publications

3902Reads

25Profile Views

Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma.

N Engl J Med 2018 04;378(15):1396-1407

From the Lymphoid Malignancies Branch (R.S., D.W.H., J.D.P., J.Q.W., S.R., M.K., R.M.Y., A.L.S., D.J.H., W. Xiao, X.Y., Y.Y., H.Z., W. Xu, W.H.W., L.M.S.), the Biometric Research Program, Division of Cancer Diagnosis and Treatment (G.W.W.), and the Laboratory of Pathology, Center for Cancer Research (E.S.J., S.P.), National Cancer Institute, and the Office of Intramural Research, Center for Information Technology (C.A.J., X.L., B.Z., W.D.), National Institutes of Health, Bethesda, and the Cancer Research Technology Program, Leidos Biomedical Research, Frederick National Laboratory for Cancer Research, Frederick (B.T., J.S., Y.Z., D.R.S.) - all in Maryland; the Department of Pathology, City of Hope National Medical Center, Duarte, CA (W.C.C.); the BC Cancer Agency, Vancouver, BC (R.D.G., J.M.C.), and the University Health Network, Laboratory Medicine Program, Toronto General Hospital and University of Toronto, Toronto (J.D.) - both in Canada; the Hospital Clinic of Barcelona, University of Barcelona, Institute for Biomedical Research August Pi I Sunyer, Barcelona (E.C., A.L.-G.); the Institute of Pathology, University of Würzburg, and Comprehensive Cancer Center Mainfranken, Würzburg (A.R.), and the Department of Clinical Pathology, Robert-Bosch-Krankenhaus, and Dr. Margarete Fischer-Bosch Institute for Clinical Pharmacology, Stuttgart (G.O.) - all in Germany; the Department of Laboratory Medicine and Pathology, Mayo Clinic, Scottsdale, AZ (L.M.R.); the National Cancer Centre of Singapore, Singapore (K.T.K.W.); Memorial Sloan Kettering Cancer Center (A.D.Z.) and Weill Cornell Medicine (J.P.L.) - both in New York; the Department of Medicine, Washington University School of Medicine, St. Louis (N.L.B.); and the Alliance for Clinical Trials in Oncology, Chicago (A.D.Z., J.P.L., N.L.B.).

View Article

Download full-text PDF

Source
http://www.nejm.org/doi/10.1056/NEJMoa1801445
Publisher Site
http://dx.doi.org/10.1056/NEJMoa1801445DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6010183PMC
April 2018

Chronic Lymphocytic Leukemia: Individualizing Treatment Approach.

J Natl Compr Canc Netw 2017 05;15(5S):713-715

Presented by Andrew D. Zelenetz, MD, PhD, Department of Medicine, Memorial Sloan Kettering Cancer Center, and Weill Cornell Medical College, New York, New York.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.6004/jnccn.2017.0081DOI Listing
May 2017

High Body Mass Index in Elderly Patients With DLBCL Treated With Rituximab-Containing Therapy Compensates for Negative Impact of Male Sex.

J Natl Compr Canc Netw 2016 10;14(10):1274-1281

From Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, Illinois; Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts; Biostatistics and Data Coordinating Center, City of Hope National Medical Center, Duarte, California; Lymphoma/Myeloma, University of Texas MD Anderson Cancer Center, Houston, Texas; Hematology and Stem Cell Transplantation, City of Hope National Medical Center, Duarte, California; University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan; Departments of Medicine and Immunology, Roswell Park Cancer Institute, Buffalo, New York; Fox Chase Cancer Center, Philadelphia, Pennsylvania; Medicine/Lymphoma, Memorial Sloan Kettering Cancer Center, New York, New York; and James P. Wilmot Cancer Center, University of Rochester, Rochester, New York.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5531178PMC
http://dx.doi.org/10.6004/jnccn.2016.0136DOI Listing
October 2016

NCCN Guidelines Insights: Non-Hodgkin's Lymphomas, Version 3.2016.

J Natl Compr Canc Netw 2016 09;14(9):1067-79

From Memorial Sloan Kettering Cancer Center; Robert H. Lurie Comprehensive Cancer Center of Northwestern University; The University of Texas MD Anderson Cancer Center; Massachusetts General Hospital Cancer Center; Stanford Cancer Institute; UCSF Helen Diller Family Comprehensive Cancer Center; Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine; The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute; Fox Chase Cancer Center; Huntsman Cancer Institute at the University of Utah; Mayo Clinic Cancer Center; Roswell Park Cancer Institute; University of Michigan Comprehensive Cancer Center; Duke Cancer Institute; Consultant; Dana-Farber/Brigham and Women's Cancer Center; Fred & Pamela Buffett Cancer Center; City of Hope Comprehensive Cancer Center; Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance; University of Colorado Cancer Center; Vanderbilt-Ingram Cancer Center; UC San Diego Moores Cancer Center; Yale Cancer Center/Smilow Cancer Hospital; University of Alabama at Birmingham Comprehensive Cancer Center; Moffitt Cancer Center; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins; St. Jude Children's Research Hospital/University of Tennessee Health Science Center; and National Comprehensive Cancer Network.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.6004/jnccn.2016.0117DOI Listing
September 2016

The Role of Biosimilars.

J Natl Compr Canc Netw 2016 05;14(5 Suppl):626-9

Presented by Andrew D. Zelenetz, MD, PhD, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, and Pamela S. Becker, MD, PhD, Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance, Seattle, Washington.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.6004/jnccn.2016.0178DOI Listing
May 2016

Surveillance imaging for lymphoma: pros and cons.

Am Soc Clin Oncol Educ Book 2014 :e388-95

From the: Division of Hospital Medicine, Department of Medicine, Washington University School of Medicine, St. Louis, MO; Lymphoma Division, Memorial Sloan Kettering Cancer Center, New York, NY; Division of Oncology, Department of Medicine, University of Nebraska; Division of Oncology, Department of Medicine, Washington University School of Medicine; and Division of Hematology/Oncology, St. Louis VA Medical Center, St. Louis, MO.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.14694/EdBook_AM.2014.34.e388DOI Listing
December 2015

Excellent outcomes and lack of prognostic impact of cell of origin for localized diffuse large B-cell lymphoma in the rituximab era.

Br J Haematol 2015 Dec 12;171(5):776-83. Epub 2015 Oct 12.

Lymphoma Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.13766DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4715539PMC
December 2015

Prognostic Value of FDG PET/CT before Allogeneic and Autologous Stem Cell Transplantation for Aggressive Lymphoma.

Radiology 2015 Nov 2;277(2):518-26. Epub 2015 Jun 2.

From the Departments of Radiology (G.A.U., J.L., H.S.), Epidemiology and Biostatistics (D.A.G., M.G.), and Medicine (C.S.S., J.M., C.H.M., A.D.Z.), Memorial Sloan-Kettering Cancer Center, 1275 York Ave, New York, NY 10065; and Departments of Radiology (G.A.U., H.S.) and Medicine (C.S.S., C.H.M., A.D.Z.), Weill Cornell Medical College, New York, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1148/radiol.2015142556DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5006668PMC
November 2015

Randomized Phase II Trial Comparing Obinutuzumab (GA101) With Rituximab in Patients With Relapsed CD20+ Indolent B-Cell Non-Hodgkin Lymphoma: Final Analysis of the GAUSS Study.

J Clin Oncol 2015 Oct 17;33(30):3467-74. Epub 2015 Aug 17.

Laurie H. Sehn, Centre for Lymphoid Cancer, British Columbia Cancer Agency and the University of British Columbia, Vancouver, British Columbia; Tara Baetz, Queen's University, Kingston General Hospital, Kingston; Rena Buckstein, Sunnybrook Health Sciences Center; Michael Crump, Princess Margaret Hospital, University of Toronto, Toronto, Ontario, Canada; Andre Goy and Luis E. Fayad, John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ; Fritz C. Offner, Institute of Hematology and Medical Oncology, University of Bologna; Pier Luigi Zinzani, Institute of Hematology "Seràgnoli" University of Bologna, Bologna; Giovanni Martinelli, European Institute of Oncology, Milano; Gianluca Gaidano, Amedeo Avogadro University of Eastern Piedmont, Novara, Italy; M. Dolores Caballero, University Hospital of Salamanca, Salamanca, Spain; Ole Gadeberg, Vejle Hospital, Vejle, Denmark; Andrew D. Zelenetz, Memorial Sloan Kettering Cancer Center, New York; Jonathan Friedberg, James P. Wilmot Cancer Center, University of Rochester, Rochester, NY; Branimir Jadkisic, Clinical Hospital Merkur, University of Zagreb, Zagreb, Croatia; Swaminathan Padmanabhan Iyer, Houston Methodist Cancer Center, Weill Cornell Medical College, Houston, TX; Deniz Sahin and Günter Fingerle-Rowson, Roche, Basel, Switzerland; Akiko Chai, Genentech BioOncology, South San Francisco, CA; Oliver Press, Fred Hutchinson Cancer Research Center, Seattle, WA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2014.59.2139DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5087315PMC
October 2015

Early Relapse of Follicular Lymphoma After Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone Defines Patients at High Risk for Death: An Analysis From the National LymphoCare Study.

J Clin Oncol 2015 Aug 29;33(23):2516-22. Epub 2015 Jun 29.

Carla Casulo and Jonathan W. Friedberg, University of Rochester, Rochester; Jonathan W. Friedberg, Memorial Sloan Kettering Cancer Center, New York, NY; Michelle Byrtek and Keith L. Dawson, Genentech, South San Francisco, CA; Xiaolei Zhou, RTI Health Solutions, Research Triangle Park, NC; Charles M. Farber, Carol G. Simon Cancer Center, Morristown, NJ; Christopher R. Flowers, Emory University, Atlanta, GA; John D. Hainsworth, Sarah Cannon Research Institute, Nashville, TN; Matthew J. Maurer and James R. Cerhan, Mayo Clinic, Rochester, MN; and Brian K. Link, University of Iowa, Iowa City, IA.

View Article

Download full-text PDF

Source
http://jco.ascopubs.org/content/early/2015/06/24/JCO.2014.59
Web Search
http://jco.ascopubs.org/cgi/doi/10.1200/JCO.2014.59.7534
Publisher Site
http://dx.doi.org/10.1200/JCO.2014.59.7534DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4879714PMC
August 2015

In Support of a Patient-Driven Initiative and Petition to Lower the High Price of Cancer Drugs.

Authors:
Ayalew Tefferi Hagop Kantarjian S Vincent Rajkumar Lawrence H Baker Jan L Abkowitz John W Adamson Ranjana Hira Advani James Allison Karen H Antman Robert C Bast John M Bennett Edward J Benz Nancy Berliner Joseph Bertino Ravi Bhatia Smita Bhatia Deepa Bhojwani Charles D Blanke Clara D Bloomfield Linda Bosserman Hal E Broxmeyer John C Byrd Fernando Cabanillas George Peter Canellos Bruce A Chabner Asher Chanan-Khan Bruce Cheson Bayard Clarkson Susan L Cohn Gerardo Colon-Otero Jorge Cortes Steven Coutre Massimo Cristofanilli Walter J Curran George Q Daley Daniel J DeAngelo H Joachim Deeg Lawrence H Einhorn Harry P Erba Francisco J Esteva Elihu Estey Isaiah J Fidler James Foran Stephen Forman Emil Freireich Charles Fuchs James N George Morie A Gertz Sergio Giralt Harvey Golomb Peter Greenberg Jordan Gutterman Robert I Handin Samuel Hellman Paulo Marcelo Hoff Ronald Hoffman Waun Ki Hong Mary Horowitz Gabriel N Hortobagyi Clifford Hudis Jean Pierre Issa Bruce Evan Johnson Philip W Kantoff Kenneth Kaushansky David Khayat Fadlo R Khuri Thomas J Kipps Margaret Kripke Robert A Kyle Richard A Larson Theodore S Lawrence Ross Levine Michael P Link Scott M Lippman Sagar Lonial Gary H Lyman Maurie Markman John Mendelsohn Neal J Meropol Yoav Messinger Therese M Mulvey Susan O'Brien Roman Perez-Soler Raphael Pollock Josef Prchal Oliver Press Jerald Radich Kanti Rai Saul A Rosenberg Jacob M Rowe Hope Rugo Carolyn D Runowicz Brenda M Sandmaier Alan Saven Andrew I Schafer Charles Schiffer Mikkael A Sekeres Richard T Silver Lillian L Siu David P Steensma F Marc Stewart Wendy Stock Richard Stone Rainer Storb Louise C Strong Martin S Tallman Michael Thompson Naoto T Ueno Richard A Van Etten Julie M Vose Peter H Wiernik Eric P Winer Anas Younes Andrew D Zelenetz Charles A LeMaistre

Mayo Clin Proc 2015 Aug 23;90(8):996-1000. Epub 2015 Jul 23.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.mayocp.2015.06.001DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5365030PMC
August 2015

Treatment response of cutaneous mantle cell lymphoma to ibrutinib and radiotherapy.

Clin Lymphoma Myeloma Leuk 2015 Jun 18;15(6):e113-5. Epub 2014 Nov 18.

Dermatology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY; Department of Dermatology, New York-Presbyterian Hospital/Weill Cornell Medical Center, New York, NY. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clml.2014.11.003DOI Listing
June 2015

Emerging treatment options for B-cell lymphomas.

J Natl Compr Canc Netw 2015 May;13(5 Suppl):666-9

Presented by Andrew D. Zelenetz, MD, PhD, Vice Chair, Medical Informatics, Department of Medicine, Memorial Sloan Kettering Cancer Center, and Professor of Medicine at Weill Medical College of Cornell University, New York, New York.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.6004/jnccn.2015.0198DOI Listing
May 2015

Prognostic value of FDG-PET prior to autologous stem cell transplantation for relapsed and refractory diffuse large B-cell lymphoma.

Blood 2015 Apr 10;125(16):2579-81. Epub 2015 Mar 10.

Division of Hematologic Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY; Department of Medicine, Weill Cornell Medical College, New York, NY;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2014-10-606939DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4624450PMC
April 2015

Favorable outcomes in elderly patients undergoing high-dose therapy and autologous stem cell transplantation for non-Hodgkin lymphoma.

Biol Blood Marrow Transplant 2014 Dec 28;20(12):2004-9. Epub 2014 Aug 28.

Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York; Department of Medicine, Weill Cornell Medical College, New York, New York.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S10838791140053
Publisher Site
http://dx.doi.org/10.1016/j.bbmt.2014.08.019DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5480286PMC
December 2014

Multidimensional single-cell analysis of BCR signaling reveals proximal activation defect as a hallmark of chronic lymphocytic leukemia B cells.

PLoS One 2014 29;9(1):e79987. Epub 2014 Jan 29.

Center Cancer Systems Biology, Memorial Sloan-Kettering Cancer Center, New York, New York, United States of America ; Program in Computational Biology, Memorial Sloan-Kettering Cancer Center, New York, New York, United States of America.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0079987PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3906024PMC
September 2014

Guidelines for NHL: updates to the management of diffuse large B-cell lymphoma and new guidelines for primary cutaneous CD30+ T-cell lymphoproliferative disorders and T-cell large granular lymphocytic leukemia.

J Natl Compr Canc Netw 2014 May;12(5 Suppl):797-800

Presented by Andrew D. Zelenetz, MD, PhD, Professor of Medicine, Weill Medical College of Cornell University, and Vice Chair, Medical Informatics, Department of Medicine, and Attending Physician in the Lymphoma Service, Memorial Sloan-Kettering Cancer Center, New York, New York.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.6004/jnccn.2014.0193DOI Listing
May 2014

International adaptation and use of NCCN Guidelines.

J Natl Compr Canc Netw 2014 May;12(5 Suppl):838-41

Presented by Ali Bazarbachi, MD, PhD, Professor of Medicine, Associate Dean for Basic Research, Director, Bone Marrow Transplantation Program, Faculty of Medicine, American University of Beirut, Beirut, Lebanon, and Andrew D. Zelenetz, MD, PhD, Professor of Medicine, Weill Medical College of Cornell University, and Vice Chair, Medical Informatics, Department of Medicine, and Attending Physician in the Lymphoma Service, Memorial Sloan-Kettering Cancer Center, New York City, New York.

View Article

Download full-text PDF

Source
http://www.jnccn.org/content/12/5S/838.full.pdf
Web Search
http://dx.doi.org/10.6004/jnccn.2014.0203DOI Listing
May 2014

Association of quantitative assessment of the intrafollicular proliferation index with outcome in follicular lymphoma.

Br J Haematol 2014 Mar 5;164(5):646-52. Epub 2013 Dec 5.

Lymphoma Service, Memorial Sloan-Kettering Cancer Center, New York, NY, USA; Hematology Division, Chaim Sheba Medical Center, Ramat Gan, Israel.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.12667DOI Listing
March 2014

Idelalisib and rituximab in relapsed chronic lymphocytic leukemia.

N Engl J Med 2014 Mar 22;370(11):997-1007. Epub 2014 Jan 22.

Weill Cornell Medical College (R.R.F.), Memorial Sloan-Kettering Cancer Center (A.D.Z.), the Department of Medicine, and Columbia University Medical Center (N.L.) - all in New York; U.S. Oncology Research, Springfield, OR (J.P.S.); Stanford University School of Medicine, Stanford (S.E.C.), and Gilead Sciences, Foster City (M.A., D.M.J., L.L.M., D.L., T.M.J., R.D.D.) - both in California; Lombardi Comprehensive Cancer Center, Georgetown University Hospital, Washington, DC (B.D.C.); Fred Hutchinson Cancer Research Center, University of Washington, Seattle (J.M.P.); St. James's University Hospital, Leeds (P.H.), and Royal Liverpool University Hospital, Liverpool (A.R.P.) - both in the United Kingdom; Hofstra North Shore-LIJ School of Medicine, New Hyde Park, New York (J.C.B.); University of California San Diego, Moores Cancer Center, La Jolla (T.J.K.); Sarah Cannon Research Institute, Nashville (I.F.); Universita Vita-Salute San Raffaele, Instituto Scientifico San Raffaele, Milan (P.G.); David Geffen School of Medicine, University of California Los Angeles, Los Angeles (H.E.); Florida Cancer Specialists, Englewood (T.E.); Centre Hospitalier Lyon-Sud, Pierre-Bénite, France (B.C.); Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago (S.M.); University of Ulm, Ulm (S.S.), and University of Cologne, Cologne (P.C., M.H.) - both in Germany; and University of Texas M.D. Anderson Cancer Center, Houston (S.M.O.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1315226DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4161365PMC
March 2014

False-Positive [18F]fluorodeoxyglucose-avid lymph nodes on positron emission tomography-computed tomography after allogeneic but not autologous stem-cell transplantation in patients with lymphoma.

J Clin Oncol 2014 Jan 18;32(1):51-6. Epub 2013 Nov 18.

All authors, Memorial Sloan-Kettering Cancer Center; and Gary A. Ulaner, Craig H. Moskowitz, and Andrew D. Zelenetz, Weill Cornell Medical College, New York, NY.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2013.50.8044
Publisher Site
http://dx.doi.org/10.1200/JCO.2013.50.8044DOI Listing
January 2014

18F-fluorodeoxyglucose positron emission tomography in the staging and prognosis of T cell lymphoma.

Leuk Lymphoma 2013 Oct 4;54(10):2163-7. Epub 2013 Mar 4.

Lymphoma Service, Division of Hematologic Oncology, Department of Medicine, Memorial Sloan-Kettering Cancer Center , New York, NY , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/10428194.2013.767901DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3915724PMC
October 2013

The impact of systemic chemotherapy on testicular FDG activity in young men with Hodgkin's lymphoma.

Eur J Nucl Med Mol Imaging 2013 May 7;40(5):701-7. Epub 2013 Feb 7.

Department of Radiology, Memorial Sloan-Kettering Cancer Center, 1275 York Ave, New York, NY 10065, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00259-012-2335-1DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4004336PMC
May 2013

Recent advances in the treatment of non-Hodgkin's lymphomas.

J Natl Compr Canc Netw 2013 May;11(5 Suppl):671-5

Lymphoma Program, Massachusetts General Hospital Cancer Center, Boston, Massachusetts 02114, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.6004/jnccn.2013.0198DOI Listing
May 2013

Incidence of hypogammaglobulinemia in patients receiving rituximab and the use of intravenous immunoglobulin for recurrent infections.

Clin Lymphoma Myeloma Leuk 2013 Apr 29;13(2):106-11. Epub 2012 Dec 29.

Lymphoma Service, Division of Hematologic Oncology, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clml.2012.11.011DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4035033PMC
April 2013

Hepatitis B virus management to prevent reactivation after chemotherapy: a review.

Support Care Cancer 2012 Nov 30;20(11):2999-3008. Epub 2012 Aug 30.

The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00520-012-1576-7DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3469760PMC
November 2012

Electronic Chemotherapy Order Entry: A Major Cancer Center's Implementation.

J Oncol Pract 2011 Jul;7(4):213-8

Memorial Hospital; Memorial Sloan-Kettering Cancer Center, New York; Weill Medical College of Cornell University, New York, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JOP.2011.000266DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3140440PMC
July 2011

Lessons from ASH 2010: a focus on NHL.

J Natl Compr Canc Netw 2011 Jan;9(1):7-11

View Article

Download full-text PDF

Source
http://dx.doi.org/10.6004/jnccn.2011.0003DOI Listing
January 2011

Pretransplantation functional imaging predicts outcome following autologous stem cell transplantation for relapsed and refractory Hodgkin lymphoma.

Blood 2010 Dec 23;116(23):4934-7. Epub 2010 Aug 23.

Lymphoma Service of the Division of Hematologic Oncology, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2010-05-282756DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3799204PMC
December 2010